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Abstract
P53-regulated proteins in transcriptional level are associated with many signal 
transduction pathways and p53 plays a pivotal role in a number of positive and neg-
ative autoregulatory feedback loops. Although POMC/α-MSH productions induced 
by ultraviolet (UV) are directly mediated by p53, p53 is related to UV-independent 
pathological pigmentation. In the process of identifying the causative gene of 
dyschromatosis universalis hereditaria (DUH), three mutations encoding amino 
acid substitutions were found in the gene SAM and SH3 domain containing 1 
(SASH1). SASH1 was identified to interact with guanine nucleotide-binding protein 
subunit-alpha isoforms short (Gαs). However, for about 90 years, the pathological 
gene and the pathological mechanism of DUH are unclear. Our study indicates that 
SASH1 is physiologically medicated by p53 upon UV stimulation and a reciprocal 
SASH-p53 inducement is existed physiologically and pathophysiologically. A novel 
p53/POMC/α-MSH/Gαs/SASH1 signal cascade regulates SASH1 to foster melano-
genesis. SASH1 mutations control a novel p53/POMC/Gαs/SASH1 autoregulatory 
positive feedback loop to promote pathological hyperpigmentation phenotype in 
DUH-affected individuals. Our work illustrates a novel p53/POMC/Gαs/SASH1 
autoregulatory positive feedback loop that is mediated by SASH1 mutations to foster 
pathological hyperpigmentation phenotype.
Keywords: SASH1 substitution mutations, p53, autoregulatory feedback loop, DUH, 
pathological hyperpigmentation phenotype
1. Introduction
The skin pigmentation is formed by the synthesis of melanin in the melano-
cytes. Melanocyte is a kind of epithelial cells mainly locating basal cell layers of 
epidermis, and a few number of melanocytes are located in mucosa. Pigment 
granules constituted with melanin can distribute and transport to neighboring 
keratinocytes [1]. Mutations in melanocortin-1-receptor (MC1R) are pivotal for 
human skin’s tanning and pigmentation. MC1R belongs to a G-protein-coupled 
receptor (GPCR) that is expressed in epidermal melanocytes in a preferential 
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manner [2]. α-Melanocyte-stimulating hormone (α-MSH), the GPCR’s ligand, 
is a propigmentation hormone which is generated and secreted by both kerati-
nocytes and melanocytes in the skin. After UV irradiation, α-MSH can activate 
GPCR. Pro-opiomelanocortin (POMC) is a multicomponent precursor for α-MSH 
(melanotropic), ACTH (adrenocorticotropic), and the opioid peptide β-endorphin, 
and α-MSH and other bioactive peptides are the cleavage products of POMC [2]. 
Normal synthesis of α-MSH and ACTH is extremely important to constitutive 
human pigmentation and the cutaneous response to UV [2].
In melanocytes, the amount and type of pigment production are regulated by 
MC1R. So MC1R is an important determiner of skin phototype, sensitivity to UV 
radiation-induced damage, and skin cancer risk [3]. The heterotrimeric G proteins 
consist of α, β, and γ subunits. Upon ligand binding, a signal is transmitted by 
GPCRs to heterotrimeric G proteins, which results in the separation of the α subunit 
from the Gβγ subunit of G proteins. ATP is catalyzed to be directly transformed 
to cAMP by the G proteins of the Gαs class and cAMP is in charge of melanogen-
esis including the sensitization of tyrosinase in melanin biosynthesis upon being 
activated by ligands such as α-MSH [4].
p53 is not only a transcriptional factor but also a tumor-suppressor protein, 
which is documented to directly sensitize the transcription of a lot of genes includ-
ing those that control cell cycle, apoptosis, and others. POMC/MSH inducement by 
UV irradiation in skin is directly regulated by p53 and POMC promoter is stimu-
lated in response to UV irradiation. p53 involves in UV-independent pathologic 
pigmentation and could imitate the tanning response [1]. Dipyrimidine C to T sub-
stitutions including CC to TT frameshift mutations in the p53 gene can be uniquely 
induced by UV in the skin of UV-irradiated mice months before tumor development 
[5]. In addition, p53 has been demonstrated to be necessary to the presentation of 
“sunburn cells,” which are a sign of sunburns [5].
DUH characterized by extensively mottled pigmentation is a heterogeneous 
disorder, which was first diagnosed by two Japanese researchers in two genera-
tions of two pedigrees for about 80 years [6, 7]. Similar Chinese DUH pedigrees 
with dyschromatosis symmetrica hereditaria (DSH) with autosomal dominant 
DUH had been reported by us in 2003 [8] and diagnosed as DUH rather than DSH 
afterward. Although novel mutations of SASH1 have been identified to be associ-
ated with dyschromatosis universalis hereditaria [9], less pathogenesis of DUH has 
not been investigated. The pathogenesis of DUH remain unclear and indefinite for 
80 years [7].
SASH1, a previously described novel family of putative adapter and scaffold 
proteins transmitting signals from the ligand to the receptor, was first showed to be 
a candidate tumor-suppressor gene in breast cancer and colon carcinoma [10–12]. 
Our previous study demonstrates that SASH1 interacts with Gαs, the downstream 
player of α-MSH/MC1R signaling pathway [13]. Our previous report indicated that 
in the several affected DUH individuals, hyperpigmented macules became more 
obvious after strong UV irradiation particularly in summer [8], but no further 
investigations was performed to identify the reasons of photosensitivity [14]. 
The significance of expression of p53/POMC/α-MSH in UV-photopigmentation 
response and UV-independent hyperpigmentation has been explained [1]. However, 
few investigations were performed to reveal that the mutations in SASH1 gene are 
related to hyperpigmentation and how these mutations result in hyperpigmentation 
phenotype.
In a word, we assume that a novel p53/POMC/α-MSH/Gαs that SASH1 involves 
in regulating UV-photopigmentation response and pathological hyperpigmentation 
phenotype.
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2. Materials and methods
2.1 DUH pathologic gene sequencing and SASH1 mutation analysis
Two Chinese pedigrees recruited from the Henan and Yunnan provinces of China 
and one American pedigree with typical features of DUH were involved in this study. 
Three DUH pedigrees with an autosomal dominant inheritance pattern were diag-
nosed by skilled clinical dermatologists. The small American pedigree only offered 
peripheral blood samples of the affected individuals for investigations. This study 
was recognized by the ethical review committees from the appropriate institutions. 
Genotyping was implemented, and the two-point LOD score was counted as our 
previous description [8]. In total, 50 family members and 500 normal individuals 
(controls) involved in the research were provided with informed consent and speci-
mens of peripheral blood DNA were acquired from all obtainable family members. 
PCR and sequencing were executed as our previous description [8]. ABI BigDye 
Terminator Cycle Sequencing Kit (Applied Biosystems, CA) was used to perform 
the sequencing on an ABI PRISM 3130 DNA Analyzer (Applied Biosystems) and 
sequence analysis software, version 3.4.1 (Applied Biosystems) were used to analyze 
the data. Sequencher 4.10.1 (Gene Codes Corp.) was used to compare the sequence 
data with SASH1 reference sequence (GenBank NM_015278.30). Nucleotide number-
ing reflects complementary DNA (cDNA) numbering, with +1 corresponding to the 
A of the ATG translation initiation codon in the reference sequence [8].
2.2 Constructing expression vectors of SASH1, Gαs, POMC, and p53
Wild-type and mutant SASH1-PEGFP-C3 and wild-type and mutant SASH1-
PBABE-Flag-puro were constructed according to the protocol of our previous study 
[13]. To generate the p53-HA-Pcna3.0, POMC-myc-Pcdna3.0 and Gαs-Pegfp-C3 
vectors, high fidelity DNA polymerase (Phusion Hot Start High Fidelity Polymerase 
from New England Biolabs, Inc. or GXL Polymerase from Takara) and the primers 
Name of primers or probes Sequences (5′–3′)
Gαs forward primer (SalI site 
included)
ACGCGTCGACATGGGCTGCCTCGGGAAC
Gαs reverse primer (XhoI site 
included)
CCGCTCGAGTTAGAGCAGCTCGTACTGACG
p53 forward primer (BamHI site 
included)
CGCGGATCCGCCACCACCATGGAGGAGCCGCAGTCAGATCCTA
p53 reverse primer (XhoI site 
included)
CCGCT CGAG TCAGTCTGAG TCAGGCCCTTCTGT
POMC forward primer (BamHI 
site included)
CGCGGATCCATGCCGAGATCGTGCTGC
POMC reverse primer (XhoI site 
included)
CCCAAGCTTTCACTCGCCCTTCTTGTAGGCGTTCTTGAT
SASH1 probe 1# GCCCAAGCTTTCACACTTGTTT
SASH1 probe 2# CCAAGACTTGCTAGAAGGAACGAGTCG
SASH1 probe 3# CGTGGCCACCTAG ACCCGAGGTG
Table 1. 
Sequences of primers or probes used in gene cloning and EMSA in this study.
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indicated in Table 1 were used to amplify the bacteria (obtained from Han Jiahuai 
Lab, Xiamen University, Xiamen, China) containing the vector of full-length CDS 
sequences of and Gαs, p53 and POMC. Mammalian expression vector (Invitrogen) 
via the relative restriction sites and sequenced.
2.3 Culture of cell and vector transfection
SK-MEL-28, HEK-293T, and A375 cells were cultured according to our previ-
ous description [15]. Normal human epithelial melanocytes (NHEMs, C-12402, 
PromoCell, Germany) were maintained in M2 medium. Lipofectamine 2000 
(11668-027, Invitrogen) as previously described [15, 16] or Entranster-D (18668-01, 
Engreen Biosystem Co., Ltd.) or polyethyleneimine (PEI) prepared by ourselves 
were, respectively, used for the transfection of SK-MEL-28, A375, B16, and HEK-
293T cells. The transfected A375 and SK-MEL-28 cells were screened with 1.5 μg/
ml puromycin or 2.0 μg/ml G418 to construct stable cell lines. Wild-type and 
mutant SASH1-pEGFP-C3 or co-transfected with wild-type SASH1-Pbabe-Flag-
puro and Gαs-Pegfp-C3 vectors were transiently introduced into HEK-293T cells 
for immunoprecipitation experiments. p53-HA-Pcdna3.0, POMC-myc-Pcdna3.0, 
Gαs-Pegfp-C3, and wild-type SASH1-pEGFP-C3 according to pairwise combination 
were introduced into NHEMs and HEK-293 or HEK-293T cells to detect the expres-
sion of exogenous p53, POMC, Gαs, and SASH1 using PEI or PromoFectin (PK-CT-
2000-MAC-1, PromoCell).
Gαs-GFP, HA-p53, myc-POMC, and GFP-SASH1 recombined vector were 
introduced into HEK-293T cells. 24 h later, Entranster™-R transfection reagent 
(18668-06, Engreen Biosystem Co., Ltd) was used to transfect Gαs- and POMC-
specific siRNAs synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China) 
to silence the expression of exogenous Gαs, p53, and SASH1 in the transfected 
HEK-293T cells. The sense/antisense sequences of each siRNA for Gαs, POMC are 
documented in Table 2.
Gene name Forward primer (5′–3′) Reverse primer (5′–3′)
SASH1 CGGGAAACGTCAAGTCGGA ATCTCCTTTCTTGAGCTTGAG
TYRP1 CACAGGCACAGGTACCACCTC CTGAACTACCCTAGGTCTTCGTT
Pmel17 AAGGTCCAGATGCCAGCTCAA CTTTCACGGCTCTAGGACGTC
Rab 27a AACTAGTGCTGCCAATGGGACA TTTGATCGCACCACTCCTTC
Gαs GTCCTTGCTGGGAAATCG CGCAGGTGAAATGAGGGTAG
p53 CCACCATCCACTACAACTACAT TCCCAGCACAGGCACAAA
POMC AGTTCAAGAGGGAGCTGACTGG CATGAAACCGCCGTAGCG
GAPDH CACCCACTCCTCCACC TTTG ACCACCCTGTTGCT GTAGCC
Gαs siRNA 1 GAGGACUACUUUCCAGAAUTT AUUCUGGAAAGUAGUCCUCTT
Gαs siRNA 2 GCAGCUACAACAUGGUCAUTT AUGACCAUGUUGUAGCUGCTT
POMC siRNA1 ACCUCACCACGGAAAGCAATT UUGCUUUCCGUGGUGAGGUTT
POMC siRNA2 AGUACGUCAUGGGCCACUUTT AAGUGGCCCAUGACGUACUTT
GAPDH GUAUGACAACAGCCUCAAGTT CUUGAGG CUGUUGUCAUACTT
Negative control UUCUUCGAACGUGUCACGUTT ACGUGACACGUUCGG AGAATT
Table 2. 
Primers used for site directed mutagenesis, real time RT-PCR and RNAi.
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2.4 Pull-down experiments and nanoflow LC-MS/MS and bioinformatic assays
Procedure of the pull-down assay, LC-MS/MS analyses, database search, and 
bioinformatic analyses for functional classification are mainly as performed as our 
previous description [13].
2.5 Immunoprecipitation and westernblotting
Transfected HEK-293T cells or HEK-293 cells or NHEMs with ectopic exog-
enous genes were washed in a gentle way for three times with PBS and lysed in 
IP-western blot lysis buffer (P0013, Beyond Time BioScience and Technology 
Company) in the presence of a complete protease inhibitor cocktail, 1 μM sodium 
orthovanadate, and 1 mM sodium fluoride per 10 cm dish on ice for 20 min to 
acquire lysisprotein. Cell lysates were centrifuged for 10 min at 12,000 rpm at 
4°C. 600 μl of supernatants of cell lysates were pre-cleaned with Protein A/G 
PLUS-Agarose (Santa Cruz Biotechnology, Inc.) for 1 h. GFP-Tag (7G9) mouse 
mAb (Shanghai Abmart, Inc.) or DYKDDDDK-Flag-Tag mouse mAb (Shanghai 
Abmart) or HA-Tag mouse mAb (Shanghai Genomics) was used to immunopre-
cipitate the corresponding proteins at 4°C for 2 h. Then, the cell lysates were mixed 
with 20 μl of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Inc.) at 4°C 
for 10 h for co-immunoprecipitation or immunoprecipitation analyses. Finally, 
immunoprecipitates were washed for three times with PBS and subjected to west-
ern blotting. GFP-Tag mouse Ab, Flag-tag mouse mAb, DYKDDDDK-Flag mouse 
mAb, GAPDH mouse mAb and anti-β-tubulin mouse mAb (Shanghai Abmart, 
Inc.), anti-Gαs rabbit polyclonal Ab (Gene Tex, Inc.), myc-tag mAb and HA-tag 
mouse mAb (Shanghai Genomics), SASH1 Rabbit mAb (Bethyl Laboratories, 
Inc.), TYRP1 (TA99) mouse mAb and melanoma gp100 Rabbit mAb (Abcam), 
Rab 27a mouse mAb (Abnova) were used for immunoblotting assay as previously 
described [17, 18].
2.6 Immunohistochemical analyses and immunofluorescence staining and 
melanin staining
2.6.1 Immunohistochemistry
All participating patients in this study were given the written informed con-
sent regarding tissue and data use for scientific purposes. Epithelial tissues from 
affected individuals with the Y551D SASH1 mutation from pedigree I were fixed 
and embedded in paraffin. Paraffin sections (5 μm) were baked at 56°C for 3 h, and 
then deparaffinized and rehydrated using xylene and an ethanol gradient. SASH1 
monoclonal antibody, rabbit anti-ACTH antibody, MiTF polyclonal antibody, the 
antibodies of melanogenesis related molecules including HMB45, TYRP1, and Rab 
27a and p53 monoclonal antibody was used to bind the corresponding proteins 
on paraffin sections, respectively. Finally, counterstaining of hematoxylin was 
performed and the sections were photographed under the positive position micro-
scope BX51.
2.6.2 Immunofluorescence (IF) and confocal microscopy detection
A375 stable cells with ectopic wild-type or mutant SASH1 in 6-well chamber 
slides were analyzed with indirect immunofluorescence analysis. SASH1 rabbit 
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mAb (Betheyl Laboratories, Inc.) and DYKDDDDK-Flag mouse mAb (Shanghai 
Genomics, China) were used to assess SASH1 localization and expression, as 
described previously [13].
2.6.3 Melanin staining
The melanin staining of paraffin sections obtained from epithelial tissues were 
performed as our previous descriptions and observed under a light microscope [18].
2.7 Quantitative RT-PCR
TRIzol reagent (Invitrogen) was used to isolate the total RNA from the different 
groups of SK-MEL-28 cells. Reverse transcription was performed according to the 
manufacturer’s protocol for the PrimeScript™ RT Reagent Kit (DRR037A, TaKaRa) 
for qRT-PCR. The sense and antisense primer sequences for SASH1, TYRP1, Pmel17, 
Rab27a, Gαs, POMC, and GAPDH are showed in Table 2. The PCR products were 
identified by agarose gel electrophoresis. The Applied Biosystems 7500 System 
was applied to detect the expression of corresponding genes with SYBR Premix Ex 
Taq™ (DRR041A, TaKaRa). The quantity of each mRNA was normalized to that of 
GAPDH mRNA.
2.8 UV irradiation
Human foreskin tissues from a 14 year-old boy were irradiated for enough 
time under a ultraviolet phototherapy instrument (NBUVB SS-05, Sigma) 
to reach the expected UV intensity. The irradiated tissues were fixed in 10% 
formalin and embedded in paraffin for immunohistochemistry analyses. We 
conformed to the guidelines of the World Medical Assembly (Declaration of 
Helsinki) to acquire the human foreskin tissues. In vitro UV experiments were 
mainly referred to the protocol of our institute [19]. HEK-293T cells and NHEMs 
transiently with ectopic myc-POMC were subcultured to approximately 70–80% 
confluence and were irradiated with 100 mJ/cm2 UVC delivered via a HL-2000 
HybriLinker with a 254 nm wavelength and followed by the indicated recovery 
time. Finally, immunobloting was performed to identify the corresponding 
proteins’ levels.
2.9 Electrophoretic mobility shift assay
Three probes binding with/without biotin targeting the promoter sequence of 
SASH1 gene were synthesized. The sequences of probes were as indicated in Table 1. 
Electrophoretic mobility shift assay was performed as described as the protocol pro-
vided with LightShift® Chemiluminescent EMSA (20148, Thermo Scientific, Pierce 
Biotechnology) to detect the bindings of SASH1 with p53 [18].
2.10 Statistical analyses
The data are indicated as mean ± standard error of the mean (SEM)s. The 
homogeneity of variance test was first used to analyze the variance homogeneity 
of data and the data were analyzed the change of variable test. Statistical signifi-
cance was determined by a one-factor analysis of variance (ANOVA) using LSD on 
SPSS version 16.0 to produce the required p-values. Cartograms were plotted with 
GraphPad Prism 5.
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3. Results
3.1  Mutations in SASH1 gene in the DUH-affected individuals result in 
up-regulated SASH1 in vitro and in vivo
The gene that is responsible for DUH had been localized to chromosome 6q24.2-
q25.2. The 10.2 Mb region on chromosome 6 (6q24.2-q25.2) containing more than 
50 candidate genes is flanked by the markers D6S1703 and D6S1708 [8]. Direct 
sequencing of the PCR products of exons amplified from genomic DNA of affected, 
unaffected, and control individuals was performed to screen the selected genes in 
this region for possible pathological mutations. 50 candidate genes were sequenced. 
Finally, in the probands in each of the two nonconsanguineous Chinese DUH-
affected pedigrees (families I and II) and in one nonconsanguineous American DUH-
affected pedigree (family III), three heterozygous mutations encoding amino acid 
substitutions in SAM and SH3 domain containing I (SASH1) were found in the three 
pedigrees. The substitution mutations in SASH1 gene were as follows: a TAC → GAC 
substitution at nucleotide 2126 in exon 14, causing a Y551D (p.Tyr 551 Asp) muta-
tion at codon 551 in family I, a CTC → CCC substitution at nucleotide 2019 in 
exon 13, causing a L515P (p.Leu to Pro) mutation at codon 515 in family II, and a 
GAA → AAA substitution at nucleotide 2000 in exon 13, resulting in a E509K (p.Glu 
to Lys) mutation in family III. These sequence alterations were identified in all of the 
affected pedigree members, but were not observed in unaffected pedigree members, 
correlating the presence of the mutations with the presence of the phenotype. In any 
of the 500 normal controls or in any of the current databases, including the HapMap 
database, these three SASH1 mutations were not found [18]. So, these three muta-
tions are impossible to be common single nucleotide polymorphisms (SNPs) [8].
In A375 stable cells with ectopic SASH1 gene mutants, mutated SASH1 were 
found to be significantly up-regulated (Figure 1B). Western blot showed that 
up-regulation of SASH1 was found in A375 cells stably expressing either wild-
type (WT-A375 cells) or mutant SASH1, when compared to the expression of 
endogenous SASH1 in A375 cells with expression of pBABE-puro empty vector 
(VECTOR-A375 cells) or BLANK-A375 cells (Figure 1B) [18].
To identify the stability of SASH1 proteins, 20 μg/ml of the protein synthesis 
inhibitor cycloheximide (CHX) was used to treat HEK-293T stable cells with ectopic 
wild-type or mutant SASH1 expressing for the indicated times to assess the half-life 
of SASH1. SASH1 protein levels were induced to decrease by CHX treatment in 
a time-course-dependent manner. Wild-type SASH1 levels was decreased with a 
half-life of approximately 4 h, however, mutant SASH1 proteins began to degrade 
with CHX treatment for 6 h or longer. Therefore, it is deduced that the three mutant 
SASH1 proteins were more steady than the wild-type, confirming the conclusion 
offered above that expression levels of mutated SASH1(s) are higher levels than that 
of wild-type (Figure 2A and B). Endogenous SASH1 was not a stable protein with 
an half-life of approximately 3 h as identified by western blot (Figure 2C) [18].
The subcellular localization of SASH1 in A375 cells and skin epithelial layers was 
further characterized. A homogenous pattern of expression of SASH1 protein was 
observed in VECTOR-A375 cells and the skin epithelial layers from normal controls 
(Figures 1C and 3-a4). However, heterogeneity expression of SASH1 protein was 
showed in WT-A375 cells and mutant-A375 cells (Figure 3-b4–e4) as well as in the 
epithelial tissues of affected individuals (Figure 1C). In addition, as identified by 
Mitf, a melanocyte indicator, most of the SASH1-positive cells were Mitf-nucleic posi-
tive-melanocytes in the epithelial tissues of DUH-affected individuals. These Mitf-
nucleic positive-melanocytes in the affected epithelial layer showed a heterogeneous 
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distribution compared to those of unaffected individuals (Figure 1C). Some Mitf-
tenuigenin-positive staining is of false positivity (Figure 1C). Melanocytes or SASH1-
positive epithelial cells not only localized at the basal layers, but also the suprabasal 
layers of the affected epidermal tissue, the phenomenon of which coincides with our 
previous descriptions that SASH1 mutations promotes melanocyte movement from 
the affected basal layers to the superficial ones [13].
3.2 SASH1 binds to Gαs and is induced by the canonical p53/POMC/Gαs cascade
SASH1 contains two functional domains, SAM and SH3 domain, which indicates 
SASH1 may plays an important role in a signaling pathway acting as a signaling mol-
ecule adapter or an associated scaffolding protein [8, 9]. Therefore, we performed 
a pull-down assay and a mass spectrometry analysis to investigate which signaling 
Figure 1. 
Increased SASH1 expression is induced by mutations in SASH1 in vitro and in vivo. (A) Substitution 
mutation sites in the SASH1 gene in three DUH pedigrees. (B) Differential and increased expression 
of mutant SASH1 proteins is detected compared to that of wild-type SASH1 in different A375 cells by 
immunoblot. (C) Immunohistochemistry detection of SASH1 and Mitf. Heterogeneous SASH1 protein 
was detected in all of the DUH-affected epithelial layers compared to that of normal controls (NC). 
Heterogeneous distribution of melanocytes is detected in the epithelial layers of DUH-affected individuals 
using Mitf compared to that of normal controls. 400× magnification. Scale bar = 20 μm. The representative 
positive cells of SASH1 and Mitf were denoted by red arrows.
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pathways are regulated by SASH1. Pull-down experiments and nanoflow LC-MS/MS 
analysis demonstrated that SASH1 interacts with Gαs and CALM, both of which are 
important in melanogenesis process (Tables 3 and 4) in WT-A375 cells. Gαs connects 
receptor-ligand associations with the activation of adenylyl cyclase and many cellular 
responses, serving as a pivotal player in the conventional signal cascades [20]. To 
investigate the associations between SASH1 and Gαs, HEK-293T cells were co-trans-
fected with Flag-SASH1 and GFP-Gαs. Exogenous SASH1 was immunoprecipitated 
with both exogenous Gαs (GFP-Gαs) and endogenous Gαs. Immunoprecipitates of 
exogenous SASH1 had different observed band sizes of Gαs (Figure 4B and C) [18].
Gαs mediates cAMP production in melanocytes which is stimulated by α-MSH 
and melanocortins [21] and our study here shows that Gαs is associated with 
SASH1. Hence, we examine whether Gαs is required for the induction of SASH1 
and how Gαs mediates SASH1 expression, we introduced exogenous p53, POMC, 
Gαs, and SASH1 gene into HEK-293T and NHEMs (normal human epithelial 
Figure 2. 
Endogenous SASH1 protein is unstable and mutation of SASH1 induces the heterogeneous expression of SASH1 
in vitro. (A) Mutant SASH1 proteins are more stable than the wild-type SASH1 protein. Stable HEK-293T 
cells were treated with CHX (20 μg/ml) for the indicated times and analyzed by western blotting. The amount 
of SASH was quantified by densitometry and normalized to β-tubulin. CHX resulted in the degradation of 
wild-type SASH1 protein, which had a half-life of 4 h. Under a 6-h or longer treatment with CHX, CHX 
began to induce the degradation of mutant SASH1 proteins. (B) The intensity of GFP-SASH1 was quantified 
by densitometry and normalized to β-tubulin (n = 3). (C) Endogenous SASH1 is an unstable protein. HEK-
293T cells were deprived of FBS for the indicated time and lysed and subjected to western blot to detect the 
endogenous SASH1 levels.
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melanocytes) to assess the effects of p53 and POMC on Gαs. Exogenous Gαs was 
induced in the co-existence of exogenous p53 and POMC (Figure 4C lane 5 and 
Figure 4D lane 5) and both inducements of exogenous Gαs and exogenous SASH1 
were observed in the co-existence of exogenous p53 and POMC in two types of 
normal cells (Figure 4C lane 6 and Figure 4D lane 6). Meanwhile, in the pres-
ence of GFP-SASH1, GFP-Gαs was also induced (Figure 4C lane 4 and Figure 4D 
Figure 3. 
Subcellular localization of SASH1. The fluorescence signals that were detected by confocal microscopy indicate 
that the overexpression or mutation of SASH1 results in the heterogeneous expression of SASH1 in vitro in A375 
stable cells. The green fluorescence represents the Flag-tag label. Both exogenous and endogenous SASH1 are 
labeled with a red fluorescent tag. The nuclei are labeled with DAPI (in blue). The yellow fluorescence indicates 
the overlap of the green and red fluorescent staining. The red arrowheads indicate the activated SASH1-
Flag fusion proteins that were expressed in the cytoplasm of WT-A375 cells or mutant-A375 cells. The blue 
arrowheads indicate the regions that do not express the activated SASH1-Flag fusion protein in the cytoplasm 
of WT-A375 or mutant-A375 cells. The endogenous SASH1 presents a uniform pattern of expression in all of 
the VECTOR-A375 cells (Figure 3A-a4). Scale bar = 5 μm.
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lane 4), which indicated that SASH1 is necessary for activation of GFP-Gαs. And 
immunoblot showed that Gαs was identified to be induced by exogenous p53 and 
SASH1 (Figure 4E and F). Our results also demonstrated that POMC was mediated 
by p53 in HEK-293T and melanocytes, which were consistent with previous conclu-
sions [1] (Figure 4G and H).
To confirm the fact that POMC, p53, and Gαs are needed for the induction of 
SASH1 and exogenous POMC, p53, Gαs, and SASH1 were transfected into HEK-
293T cells and followed by silence of Gαs and POMC by two specific pairs of siRNA, 
respectively. As identified in HEK-293 cells, deletion of Gαs gene directly induced 
significant reduction of SASH1 (Figure 5C and D). Deletion of POMC by siRNA 
resulted in the downregulation of Gαs and SASH1 (Figure 5E and F). Taken above, 
Protein name Score Protein possibility Total peptide Unique peptide
SASH1 200.3 1 37 20
Gαs 20.2 1 8 5
CALM1 10.2 1 7 3
Affinity-purified proteins were identified by MS analysis and the detailed peptide sequences are summarized in  
Table 2.
Table 3. 
Proteins interacting with SASH1 were identified by MS analysis.
Protein name Peptide sequence
SASH1 (O94885) K.KPSTEGGEEHVFENSPVLDERS
R.AVLLTAVELLQEYDSNSDQSGSQEKL
K.GEDVGYVASEITMSDEERI
R.VSQDLEVEKPDASPTSLQLR.S
R.VHTDFTPSPYDTDSLKI
K.LLEEEDLDELNIRD
K.LHAEGIDLTEEPYSDKH
K.PGAGTSEAFSR.L
KPLFFDGSPEKPPEDDSDSLTTSPSSSSLDTWGAG
K.MGTFFSYPEEEKA
KMITIEEALARL
RSLHVGSNNSDPMGKE
SLHVGSNNSDPMGK
ITIEEALAR
MITIEEALARL
RGVDLETLTENKL
IPSQPPPVPAK
TIEEALAR
KYFWQNFRK
SALYSGVHK
Gαs (P63092) EAIETIVAAMSNLVPPVELANPENQFR
YTTPEDATPEPGEDPR
IEDYFPEFAR
MFDVGGQR
VLTSGIFETK
CALM1 (P62158) R.EADIDGDGQVNYEEFVQMMTAK
A375 stable cells with ectopic SBP-FLAG-SASH1 expressing were lysed, immunoprecipitated with SBP beads and 
digested with trypsin. The liquid supernatant was collected, dried, and dissolved in 10% (v/v) acetonitrile and 0.8% 
formic acid solution. Nanoflow LC-MS/MS analyses were performed to identify the peptides.
Table 4. 
SBP-FLAG-SASH1 affinity purification was performed to identify the peptide sequences of the binding 
complex of SASH1 protein.
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it is believed that Gαs serves as a pivotal downstream of p53/POMC cascade and 
SASH1 is regulated by a novel p53/POMC/Gαs cascade.
3.3 P53 physiologically triggers SASH1 upon UV irradiation
To reveal the phenomenon that P53 physiologically triggers SASH1, discarded 
normal human foreskin samples were irradiated to gradually increased dose of 
UV and stained for the histological analyses of p53, ACTH/POMC, and SASH1. 
Figure 4. 
Gαs binds to SASH1 and is a central downstream player of p53/POMC cascade. (A) Immunoprecipitation-
Western blot (IP-WB) was performed to identify the interactions between GFP-SASH1 and endogenous 
Gαs in HEK-293T cells. pEGFP-C3-SASH1-recombined vectors were introduced into HEK-293T cells. At 
24 h after transfection, GFP-SASH1 was immunoprecipitated and the associated endogenous Gαs was 
identified by immunoblot analysis using a Gαs antibody. (B) Exogenous Gαs binds to exogenous SASH1. 
pEGFP-C3-Gαs and pBABE-puro-Flag-SASH1 vectors were co-introduced into HEK-293T cells. At 36 h 
after transfection, exogenous SASH1 (Flag-SASH1) was immunoprecipitated and the associated GFP-Gas 
was detected by western blot analysis using an anti-GFP antibody. At 36-h post-transfection, Flag-SASH1 
was immunoprecipitated and the associated exogenous Gαs (GFP-Gas) was detected by immuoblot using an 
anti-GFP antibody. (C) and (D) P53, POMC, and SASH1 are essential to the activation of Gαs. HA-p53, 
myc-POMC, and GFP-SASH1, respectively, according to different manners of combination were introduced 
into HEK-293 cells and NHEMs. After 36 h after transfection, immunoblotting was performed to detect the 
protein levels in two normal cells along with GAPDH as loading control. (E) Exogenous Gαs (GFP-Gαs) 
is induced by exogenous p53 (HA-p53). HEK-293 cells were transfected with HA-p53 and GFP-Gαs. At 36-h 
post-transfection, the transfected HEK-293 cells were lysed and subjected to western blot analyses. GFP-Gαs was 
induced by gradually increased amounts of HA-p53. (F) Exogenous Gαs (GFP-Gαs) is induced by exogenous 
SASH1 (GFP-Gαs). GFP-Gαs and GFP-SASH1 were transfected into HEK-293T cells. GFP-Gαs was induced 
by gradually increased doses of GFP-SASH1. (G) and (H) Exogenous POMC (myc-POMC) was induced by 
increased dose of exogenous p53 in HEK-293T cells and NHEMs. Different amounts of HA-p53 vector and a 
certain amounts of myc-POMC vector were introduced into HEK-293T cell for expression. Exogenous POMC 
RNA levels were quantified by quantitative RT-PCR and normalized to GAPDH. The expression of HA-p53 
and myc-POMC was analyzed by immunoblot using GAPDH as loading control.
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Immunohistochemical (IHC) analyses demonstrated p53 is quickly induced in basal 
layers at the 0.5 J/cm2 dose of UV exposure. The quick inducement of SASH1 and 
POMC/ACTH at UV irradiation 1.0 J/cm2 dose in melanocytes is followed closely 
Figure 5. 
Expression of SASH1 was mediated by a novel p53/POMC/Gαs/SASH1 signal cascade. (A) and (B) 
Endogenous and exogenous SASH1 (GFP-Gαs) are both induced by Gαs. HEK-293T cells were transfected with 
gradually increasing doses of exogenous Gαs and exogenous SASH1, or only different amounts of exogenous 
Gαs. The protein levels of endogenous or exogenous SASH1 were assessed by immunoblot. (C) and (D) Gαs is 
essential for the induction of SASH1. Exogenous Gαs, POMC, and SASH1 as well as increasing doses of HA-p53 
according to different combinations were transfected into HEK-293 cells. Among the transfected HEK-293 
cells, two groups of cells were afterward transfected with two pairs of effective Gαs siRNAs and negative 
control (NC) siRNA. The corresponding protein levels were assessed by western blot. (E) and (F) POMC is 
essential for the induction of SASH1 and Gαs. HEK-293 cells were transfected with GFP-Gαs, myc-POMC, and 
GFP-SASH1 as well as increasing dose of HA-p53 according to different manner of combinations. Among the 
transfected HEK-293 cells, two groups of HEK-293 cells were later silenced with two pairs of effective POMC 
siRNAs and NC siRNA.
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by p53 up-regulation (Figure 6A). Previous study had indicated that up-regulated 
POMC gene is induced at both protein and mRNA levels following UV exposure of 
skin [22, 23]. Followed the previous reports [1], a 100 J/m2 UVB dose was admin-
istered in this study. The 100 J/m2 UVB dose equates to the standard erythema 
dose (SED), which is commonly used as a measure of sunlight [24]. Therefore, 
both endogenous p53 and SASH1 protein levels in HEK-293T cells and NHEMs 
with ectopic exogenous POMC after UV irradiation were assessed by immunoblot. 
Expression of exogenous POMC and endogenous SASH1 was markedly induced 
by 6 h after UV irradiation, which accords with its known stabilization by UV in 
NHEMs. At 24 h, in NHEMs, UV irradiation maximally promoted the expression 
of POMC, p53, and SASH1 protein (Figure 6B). Similar induction of exogenous 
POMC and endogenous p53 and SASH1 was detected in HEK-293T cells after UV 
irradiation (Figure 6C). Hence, it is believed that both POMC and SASH1 serve as 
novel downstream players which respond to p53 inducement by UV irradiation.
Figure 6. 
SASH1 is induced physiologically by p53 after UV irradiation. (A) Upon UV irradiation or without UV 
irradiation, immunohistochemistry analyses of p53, POMC, and SASH1 in human foreskin indicated that 
p53 is activated by UV-induced-increase of POMC and SASH1. The human foreskin tissues obtained from a 
14-year-old boy were irradiated at different doses of UV intensity, then fixed in 10% formalin and embedded 
in paraffin for immunohistochemical analyses. Scale bar: 20 μm. The representative positive cells of p53, 
ACTH, and SASH1 were donated by red arrows. (B) and (C) NHEMs and HEK-293T cells with ectopic 
exogenous POMC (myc-POMC) expression were irradiated with UV irradiation (100 mJ/cm2) and recovered 
for the indicated times. Transfected cells were lysed and at different time-points after irradiation as indicated. 
Western blot was used to detect the protein levels of endogenous p53, endogenous SASH1, and exogenous POMC 
along with GAPDH or beta-tubulin as a loading control.
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3.4 p53-SASH1 reciprocal inducement in normal cells
To assess whether p53 is required for the inducement of SASH1, exogenous p53, 
and POMC gene were transfected into HEK-293T and NHEMs to test the induction 
of p53 and POMC to SASH1. In NHEMs and HEK-293T cells with ectopic of POMC 
(myc-POMC) in NHEMs and HEK-293T cells, exogenous SASH1 were induced to 
up-regulate by p53 (Figure 7). Increased protein levels of exogenous SASH1 was 
induced by increasing amounts of exogenous p53 in two normal cells (Figure 8A 
and B). On the contrary, exogenous p53 (HA-p53) was also triggered by increasing 
amounts of exogenous SASH1 (Figure 8C and D). The induction of exogenous 
SASH1 to endogenous p53 was also identified. It has been documented that, in two 
types of normal cells, increased endogenous p53 was induced by increasing doses of 
exogenous SASH1 (Figure 8E and F).
Since SASH1 is mediated by p53, we want to investigate whether there is a direct 
relationship between SASH1 and p53. As indicated in Figure 9A and B, HA-p53 did 
not bind to GFP-SASH. So, we tested the proximal 1 kb promoter region of the SASH1 
gene to find the consensus transcription-factor-binding elements that are conserved 
between human, rat, and mouse. Among the various consensus elements searched 
for, p53 gene was remarkable. A most possible p53-binding site, sequence of which is 
“tgcccaagctttcacacttgttt” was identified in the SASH1 5′ flanking region about 550 bp 
upstream of the transcription initiation site in humans (Figure 9C). So, three synthe-
sized probes were used to investigate the associations of p53 protein with SASH1 gene 
promoter. However, analyses of electrophoretic mobility shift assay (EMSA) revealed 
that there was no p53 protein bind the promoter region of the SASH1 gene (Figure 9D).
In summary, it is believed that SASH is regulated by the p53/POMC/α-MSH/
Gαs signal cascade and p53/POMC/α-MSH/Gαs cascade and SASH1 constitute a 
novel autoregulatory loop. The p53/POMC/α-MSH/Gαs/SASH1 regulatory loop 
acts as an auto-feedback circuit to regulate the p53-SASH1 reciprocal inducement 
(Figure 8G).
Figure 7. 
Exogenous p53 triggers expression of SASH1. (A) Exogenous p53 caused up-regulation of exogenous SASH1 in 
HEK-293T cells. HA-TP53, GFP-SASH1, and myc-POMC were transfected into HEK-293T cells for transient 
expression. Cells were lysed in 0.5% NP40 buffer containing protease inhibitors and subjected to western blot 
along with GAPDH as loading control. (B) Exogenous p53 caused up-regulation of exogenous SASH1 in NHEMs.
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Figure 9. 
p53 is not associated with SASH1 and SASH1 is not transcriptionally regulated by p53. (A) and (B) HEK-293T 
cells were co-transfected with the pEGFP-C3-SASH1 and Pcdna 3.0-HA-p53 vectors. At 24-h post-transfection, 
GFP-SASH1 was immunoprecipitated and the associated HA-p53 was detected by western blot analysis using 
an anti-HA antibody. Similarly, HA-p53 was immunoprecipitated and the associated GFP-SASH was detected 
by western blot analysis using an anti-GFP antibody. (C) Showed a schematic representation of the SASH1 
locus, which indicates location of a p53-binding consensus sequence. (D) EMSA analyses demonstrated that 
there was none of among three probes of SASH1 gene promoter to bind p53 recombined protein.
Figure 8. 
There is a reciprocal induction between p53 and SASH1 in normal cells. (A) and (B) Exogenous SASH1 was 
triggered by exogenous p53 (HA-p53) in a dose-dependent manner. Different amounts of HA-TP53 plasmid 
were introduced into HEK-293T cells and NHEMs as indicated. After 48-h post-transfection or transfection, 
total RNA of HEK-293T cells and NHEMs was extracted and exogenous SASH1 RNA levels were assessed 
by quantitative RT-PCR and normalized to GAPDH. Expression of exogenous p53 protein and SASH1 were 
analyzed by western blot along with GAPDH as a loading control. (C) and (D) Protein and RNA levels of 
exogenous p53 were promoted by exogenous SASH1 promotes expression. Different amounts of GFP-SASH1 
plasmid and a certain amount of exogenous p53 were transfected to HEK-293T cells and NHEMs cells. As 
revealed by QRT-PCR and western blot, enhanced expression of exogenous TP53 was induced by increasing 
amounts of GFP-SASH1. (E) and (F) Increased endogenous p53 was induced by exogenous SASH1. Different 
amounts of GFP-SASH1 were transfected in to HEK-293T cells and NHEMs. At 36 h after transfection, cells 
were lysed and subjected to western blot to analyze the expression of GFP-SASH1 with GAPDH as loading 
control. Results are the representative of three independent experiments. (G) A novel reciprocal induction of 
p53 and SASH1 is mediated by an autoregulatory p53/POMC/Gαs/SASH1 loop. p53 is activated by different 
types of stress, which fosters POMC, Gαs, and SASH1 successively. The inducement of SASH1 by p53/POMC/
Gαs cascade promotes the up-regulation p53 in nucleus, then induced nucleic p53 conversely activates POMC/
Gαs/SASH1 cascade, which consists an autoregulatory p53/POMC/Gαs/SASH1 loop.
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3.5 Enhance expression of p53 and POMC is induced by SASH1 mutations
SASH1 up-regulation is mediated by SASH1 mutations, which is unfathomable 
enigma to us for lone time. Therefore, HEK-293T cells and NHEMs were transfected 
with wild-type or mutant SASH1 (wt SASH1 or mut SASH1), exogenous p53 and 
exogenous POMC to assess the effects of SASH1 mutations on p53 and POMC. As 
demonstrated in Figure 10A and B, increased expression of p53 and POMC was 
induced by SASH1 mutations. The effects of SASH1 mutations on endogenous p53 
at protein level were also assessed. Increased endogenous p53 was also induced by 
mutated SASH1 (Figure 10C and D). In order to identify that p53 is induced by 
SASH1 mutations in vivo, immunostaining of p53 in the affected epithelial tissues 
with SASH1 Y551D mutation was performed. IHC analyses indicated that more 
nucleic expression of p53 in epithelial tissues and more p53-positive cells in affected 
epithelia layers were induced by SASH1 Y551D mutation (Figure 10E).
All of these indicate that not only SASH1 is positively regulated by the p53/POMC/
α-MSH/Gαs/SASH1 autoregulatory loop, but also SASH1 mutations serve more as 
molecular rheostats rather than an on-off switch to control this regulatory loop.
3.6 Expression of melanosomes matrix molecules was triggered by SASH1 
mutations
Since there is a SASH1-p53 autoregulatory loop, the changes of downstream 
partners of SASH1 need to be tested. Therefore, we further identified the effects 
Figure 10. 
p53 and POMC are induced to be increased SASH1 mutations. (A) and (B) Up-regulated SASH1 induced 
by SASH1 mutations promotes the expression of exogenous p53 and exogenous POMC in HEK-293T cells and 
NHEMs. Wt and mutant SASH1, exogenous p53 and exogenous POMC were introduced into HEK-293T cells 
and NHEMs. At 48-h post-transfection, immunoblot were performed to detect the corresponding protein levels. 
(C) As identified by IHC analyses, high expression of endogenous p53 was induced by Y551D-SASH1 mutation 
and more p53-positive epithelial cells were detected in the affected epithelial tissues. Affected epithelial tissues 
with Y551D SASH1 mutation from pedigree I as well as normal epithelial tissues were fixed and embedded 
in paraffin for immunohistochemistry detection. Scale bar: 20 μm. The representative positive cells of p53 are 
donated by red arrows. (D) and (E) Western blot indicated that increased endogenous p53 was induced by 
SASH1 mutations in HEK-293 cells and NHEMs.
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of mutated SASH1 on the protein levels of matrix proteins and transport proteins. 
Enhanced expression of TYRP1, Rab 27a, Pmel17, and tyrosinase in SK-MEL-28 
cells, a pigmented melanoma cell line and NHEMs was significantly induced by 
SASH1 mutations (Figure 11A and B). QRT-PCR also indicated that Pmel17, TYRP1, 
and Rab 27a were up-regulated by mutations of SASH1 in SK-MEL-28 stable cells 
(Figure 11C). Pmel17, TYRP1, and Rab 27a was heterogeneously distributed in the 
epithelial cells in the tissues of DUH-affected individuals as demonstrated by IHC 
analyses (Figure 11D and E). Increased levels of melanogenesis molecules were 
observed in some hyperpigmentation areas in the affected epithelial layers. In the 
hyperpigmentation plaques, the superfluous production and secretion of melanin 
was clearly presented in the basal layers and in the suprabasal layers of the affected 
epidermal as (Figure 11D).
4. Conclusion
Our study reveals that a novel p53-SASH1 reciprocal induction triggers pig-
mentation of skin through an autoregulatory p53/POMC/α-MSH/Gαs/SASH1 loop. 
SASH1 mutations enhance SASH1-mediated induction of p53 and POMC. POMC 
is induced by p53 overexpression and resulted in UV-dependent hyperpigmenta-
tion UV-independent pathological hyperpigmentation [1]. Our work indicates that 
POMC up-regulation is induced by SASH1 mutations, which ultimately results 
Figure 11. 
Increased production of melanogenic components and heterogeneous distribution of melanin in vivo were 
induced by SASH1 mutations. (A) Up-regulation of melanogenic components including TYRP1, Pmel17, 
tyrosinase, and Rab 27a were induced by SASH1 mutations in stable SK-MEL-28 cells. (B) Up-regulation 
of Rab 27a and tyrosinase was also induced by SASH1 mutations. The SASH1 gene (wt and mutant) was 
introduced into NHEMs and western blot was performed to determine the effect of SASH1 mutations on 
melanogenic components. (C) As identified by QRT-PCR, up-regulation of Pmel17, TYRP1, and Rab 27a in 
stable SK-MEL-28 cells was induced by SASH1 mutations (n = 4, mean ± standard error). (D) As identified 
by immunochemistry detection, heterogeneous distribution of Rab 27a and melanin were observed in the 
epithelial layers of the affected individuals. (E) Immunochemical analyses indicated that expression of Pmel17 
and TYRP1 was heterogeneously distributed in all of the epithelial layers of the epidermal tissues from the 
DUH-affected individuals. Pmel17, TYRP1, and Rab 27a: 400× magnification, bar = 20 μm; melanin: 1000 
magnification. Scale bar: 20 μm. The representative positive cells of Rab 27a, Pmel17, TYRP1, and melanin 
were indicated by red arrows.
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in the pathological hyperpigmentations of affected DUH individuals. These data 
indicate that SASH1 activation induced by mutations in melanocytes acts as a “UV 
sensor/effector” for skin pigmentation or SASH1 mutations-mediated up-regulation 
is the “chief criminal” of pathological hyperpigmentation of DUH, and its underly-
ing mechanistic role is SASH1-p53 reciprocal inducement. Our data indicate that 
the definitions of the positive feedback p53/POMC/α-MSH/Gαs/SASH1 loop help us 
to recognize an important linkage between the p53 pathway and MC1R pathway by 
SASH1.
Recently, a c.1067T>C (p.Leu356Pro) mutation in exon 3 of ABCB6 (ATP-
binding cassette subfamily B, member 6) was found in a large five-generation 
Chinese family with DUH family. Two additional missense mutations, c.508A>G 
(p.Ser170Gly) in exon 1 and c.1736G>A (p.Gly579Glu) in exon 12 of ABCB6 were 
found in two out of six patients using sporadic DUH patients [25]. Ac.1663C>A, 
(p.Gln555Lys) missense mutation in ABCB6 was identified in a Chinese family 
with typical features of autosomal dominant DUH. Two deletion mutations (g.776 
delC, c.459 delC) in ABCB6 were found in an unrelated sporadic affected individual 
[26]. In addition, missense mutations in ABCB6 were also found in the sporadic 
affected DUH individuals [27, 28]. Silence of ABCB6 by siRNA destroyed PMEL 
amyloidogenesis in early melanosomes and resulted in aberrant increase of multi-
lamellar aggregates in pigmented melanosomes. In the retinal pigment epithelium 
of ABCB6 knockout mice, morphological analysis indicated an obvious decrease of 
melanosome numbers [29]. All of these sequencing results and functional analyses 
of causing genes responsible for DUH indicate there exist novel pathogenicity genes 
and novel gene variations which is responsible for pathogenesis of DUH or there 
exists novel subtype of DUH.
The transcriptional network of p53-responsive genes produces proteins that 
interact with a large number of other signal transduction pathways in the cell and 
a number of positive and negative autoregulatory feedback loops act upon the p53 
response [30]. Feedback loops of p53 and p53-responsive genes provide a means to 
connect the p53 pathway with other signal transduction pathways and coordinate 
the cellular signals for growth and division [30]. Our findings suggest that SASH1 
serves as a “Hinge” to connect p53/POMC/α-MSH pathway with MC1R/Gαs/cAMP/
PKA cascade to form an autoregulatory p53/POMC/Gαs/SASH1 circuit to mediate 
the melanogenesis process [18, 31].
Most recently, SASH1 is showed to involve in autosomal-dominant lentiginous 
[32] and autosomal-recessive SASH1 variants (c.1849G>A; p.Glu617Lys), which are 
associated with a new genodermatosis with a pigmentation defects, palmoplantar 
keratoderma and skin carcinoma and SASH1 is first reported to be predisposed 
to skin cancer [33]. Dyschromatosis universalis hereditaria (DUH) is a clinically 
heterogeneous disorder that presents as generalized mottled pigmentation and 
was first reported by Ichigawa and Hiraga in 1933 [7]. Stuhrmann and colleagues 
identified the first locus responsible for autosomal-recessive DUH, and this findings 
is consistent with recent evidence demonstrating that DSH and DUH are genetically 
distinct disorders [34]. Zhang et al. mapped the causative gene of DSH to 1q11-1q21 
and found that a novel mutation of a heterozygous nucleotide A → G at position 
2879 in exon 10 of the DSRAD gene is involved in DSH [35]. Subsequent research on 
dyspigmentation has demonstrated that the pathogenic genetic variant that causes 
DSH is localized to the DSRAD gene on chromosome 1q [15, 36–41]. Expanding 
Stuhrmann and Nuber’s findings and our own previous work providing photo-
graphic evidence of dyschromatosis presenting as large hyperpigmented bodies on 
DUH-affected individuals [6, 8, 34], we believe that we have discovered the first 
locus associated with autosomal dominant DUH, identifying SASH1 as the causative 
gene of autosomal dominant DUH.
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Our findings first identify the pathological gene of DUH and reveal the patho-
logical mechanism of hyperpigmentation patches of DUH-affected individuals. In 
addition, our work will enrich the crosstalk of p53 pathway with other transduc-
tion pathways in cells and give a new definition of the p53-responsive genes and 
their associations, which will perfect the p53 programmed responses to stress and 
pathologic conditions.
Acknowledgements
We thank Central Laboratory at Yongchuan Hospital, Chongqing Medical 
University and Clinical Research Center, the Affiliated Hospital, Guizhou 
Medical University for housing the experiments. This work was supported 
by the Shanghai Municipal Commission of Science and Technology Program 
(09DJ1400601), the 973 Program (2010CB529600, 2007CB947300), the 
Yongchuan Hospital Project, Chongqing Medical University (YJYJ201347), 
Chongqing Education Commission Project (KJ1400201), and Guizhou’s 
Introduction Project of Million Talents.
Conflict of interest
No conflict between the authors.
Notes/thanks/other declarations
The chapter text was mainly referred to our article entitled as “A Novel P53/
POMC/Gαs/SASH1 Auto-regulatory Feedback Loop Activates Mutated SASH1 
to Cause Pathologic Hyper-pigmentation” (Journal of Cellular and Molecular 
Medicine 2017, 21(4):802-815) which we published in journal of cellular and 
molecular medicine in April, 2017. In this chapter, we rewrite the chapter text 
according to the suggestions of reviewers.
The chapter figures were taken from the figures and supplementary figures of 
our article entitled as “A Novel P53/POMC/Gαs/SASH1 Auto-regulatory Feedback 
Loop Activates Mutated SASH1 to Cause Pathologic Hyper-pigmentation”. The 
chapter tables were taken from the supplementary tables of our published article.
Declarations
Our article entitled as “A Novel P53/POMC/Gαs/SASH1 Auto-regulatory 
Feedback Loop Activates Mutated SASH1 to Cause Pathologic Hyper-pigmentation” 
is an Open Access article published under the terms of the Creative Commons 
Attribution License (CC BY). We are allowed to reuse the material without having 
to obtain permission provided that the original source of publication.
Appendices and nomenclature
ABCB6 ATP-binding cassette subfamily B, member 6
ACTH adrenocorticotropic
α-MSH α-melanocyte stimulating hormone
21
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
A Novel P53/POMC/Gas/SASH1 Autoregulatory Feedback Loop and Pathologic…
DOI: http://dx.doi.org/10.5772/intechopen.81567
Author details
Ding’an Zhou1*, Jiawei Zeng2, Xing Zeng3, Yadong Li4, Zhixiong Wu4, Xin Wan4, 
Pingshen Hu1 and Xiaodong Su1
1 Clinical Research Center, The Affiliated Hospital, Guizhou Medical University, 
Guiyang, Guizhou, China
2 Department of Clinical Laboratory, Mianyang Central Hospital, Mianyang, Sichuan, 
China
3 The Second Affiliaed Hospital, Chongqing Medical University, Chongqing, China
4 Clinical Medical College, Guizhou Medical University, Guiyang, Guizhou, China
*Address all correspondence to: 460318918@qq.com
cAMP cyclic adenosine monophosphate
CDS coding sequence
CHX cycloheximide
DSRAD double-stranded RNA-specific adenosine deaminase
DSH dyschromatosis symmetrica hereditaria
DUH dyschromatosis universalis hereditaria
EMSA electrophoretic mobility shift assay
GAPDH glyceraldehyde phosphate dehydrogenase
Gαs guanine nucleotide-binding protein subunit-alpha isoforms short
GPCR G-protein-coupled receptor
GS Griscelli syndrome
IF immunofluorescence
IHC immunohistochemical
LC-MS/MS liquid chromatograph-mass spectrometer
LOD log odds
LSD least-significant-difference
MC1R melanocortin-1-receptor
Mitf microphthalmia-associated transcription factor
NHEMs normal human epithelial melanocytes
PEI polyethyleneimine
POMC pro-opiomelanocortin
QRT-PCR quantitative reverse transcriptase polymerase chain reaction
RT-PCR reverse transcriptase polymerase chain reaction
SASH1 SAM and SH3 domain containing 1
SED standard erythema dose
TYRP1 tyrosinase protein1
UV ultraviolet
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